Document:

EX-10.2

 EXHIBIT 10.2 
 CONSENT AGREEMENT 
 AND AMENDMENT NO. 2 TO LOAN AGREEMENT 

This CONSENT AGREEMENT AND AMENDMENT NO. 2 TO LOAN AGREEMENT (this “Agreement”), dated as of June 29, 2012, is by
and among CAPELLA HEALTHCARE, INC. (the “Company” and a “Borrower”), THE BORROWING SUBSIDIARIES SIGNATORY HERETO (each a “Borrower” and together with the Company, “Borrowers”), THE GUARANTYING
SUBSIDIARIES SIGNATORY HERETO (collectively, “Subsidiary Guarantors”), THE LENDERS PARTY TO THIS AGREEMENT, and BANK OF AMERICA, N.A., as agent for the Lenders (“Agent”). Capitalized terms used herein but not
otherwise defined herein shall have the meanings given such terms in the Loan Agreement. 
 RECITALS: 

A. The Borrowers, the Subsidiary Guarantors, the Lenders and the Agent are parties to that certain Loan and Security Agreement dated as
of June 28, 2010 (as its terms have been amended, modified, waived or supplemented, the “Loan Agreement”). 
 B.
Muskogee Regional Medical Center, LLC (“MRMC”) has entered into an Asset Purchase Agreement dated as of May 11, 2012 as amended by an Amendment No.1 to the Asset Purchase Agreement dated as of June 29, 2012 (as so amended, the
“APA”) and agreements, instruments and documents related thereto (collectively, the “APA Related Documents”), with Muskogee Community Hospital LLC (“MCH”), MCH Management LLC (“Management”), Synergy Healthcare
Partners, LLC, Muskogee Community Healthcare, LLC (“Community”) and each of the beneficial owners of the Equity Interests of Management. Management owns 100% of the membership interests of MCH and MCH owns and operates Muskogee Community
Hospital, a 45-bed acute care hospital (the “Hospital”) located at 2900 North Main, Muskogee, Oklahoma (the “Facilities”). MRMC’s obligations under the APA are subject to, among other things, obtaining the consent set forth
in Section 1.01 hereof. 
 C. On the Closing Date (as used herein, such term shall have the meaning set forth in the APA)
(i) MRMC will purchase from MCH, and MCH will sell to MRMC, substantially all of the assets relating to the ownership and operation of the business operations of the Hospital and all other business operations currently being conducted by MCH at
the Facilities (collectively, the “Business”), except for the Real Estate, improvements and Equipment of the Business (collectively, the “Retained Assets”) and certain other excluded assets and MRMC will assume from MCH, and MCH
will assign to MRMC, certain of MCH’s obligations and liabilities with respect to the operation of the Business, in each case in accordance with the terms and conditions of APA (collectively, the “Asset Purchase”); (ii) MRMC will
lease from MCH, and MCH will lease to MRMC, the Retained Assets, pursuant to the terms and conditions of a Master Lease Agreement (the “Lease”), which will include an option to purchase the Retained Assets exercisable on or about
July 20, 2014 at the price set forth on Schedule 11.1 to the Lease and at the end of the initial term or renewal term at fair market value, as more specifically set forth in the Lease (the “Purchase Option”); MRMC’s obligations
under the Lease will be unconditionally guarantied by the Company (collectively, the “Transaction”). The Company will also guaranty certain obligations of MRMC under the APA. 

 D. The Lease will be a true operating lease for tax purposes, but the Company will account
for the Lease as a Capital Lease and the incurrence of the obligations under the Lease and the guaranty of such obligations requires consent of the Required Lenders under the terms of the Loan Agreement. 

E. The Borrowers and Guarantors have requested that the Required Lenders consent to the execution and delivery of the APA, the
consummation of the Transaction and the performance of MRMC’s and the Company’s obligations (i) under the Lease and guaranty thereof; (ii) customary and reasonable indemnification and reimbursement obligations under the APA; and
(iii) under the Promissory Note (as defined in the APA) (collectively, the “APA Obligations”). 
 NOW,
THEREFORE, in consideration of the premises and the mutual covenants hereinafter contained, the parties hereto agree as follows: 
 SECTION 1.01 Consent. Each of the undersigned Lenders hereby consents to (i) MRMC’s and the Company’s execution and delivery of the APA and the APA Related Documents
and (ii) the consummation of the Transaction by MRMC, the Company and their Affiliates, including (a) the consummation of the Asset Purchase, (b) the execution and delivery of the Lease by MRMC; (c) the execution and delivery of
the Promissory Note, (d) the performance of any APA Obligations and (e) the execution and delivery of the Company’s unconditional guaranty of the MRMC’s obligations under the Lease and APA Obligations; provided that with
respect to this clause (ii), the conditions set forth in Section 1.04 hereof are fully satisfied or waived in writing by the Agent. This consent is given for the specific instance and for the limited purpose set forth herein. For the
avoidance of doubt, this consent is not intended (and shall not be deemed) to be a consent to the acquisition of the Retained Assets by any Credit Party, whether pursuant to the Purchase Option, the Option Rider (as such terms are used in the Lease)
or otherwise and (i) the acquisition of the Retained Assets shall satisfy the conditions set forth in the definition of Permitted Acquisition (regardless of whether any such acquisition is accounted for or deemed an asset purchase, prepayment
of the Lease or otherwise) or require the consent of the Required Lenders and (ii) upon a consummation of the acquisition of the Retained Assets that satisfies such conditions, to the extent that the cancellation or extinguishment of the Lease
in connection therewith may be deemed to constitute an Asset Disposition, prepayment of Debt, termination of a Material Contract or other Default or Event of Default under the Loan Agreement, the Lenders shall be deemed to have consented thereto.

 SECTION 1.02 Amendment. Subject to the covenants, terms and conditions set forth herein and in reliance
upon the representations and warranties set forth herein, the following amendments to the Loan Agreement shall become effective upon the Amendment No.2 Effective Date: 

(a) Section 1.1 of the Loan Agreement is amended by adding the following definitions in proper alphabetical order:

 “Amendment No. 2 Effective Date: means the date of delivery by Company of a certificate
certifying and confirming the execution and delivery of the Master Lease Agreement and the closing and consummation of the related transactions.” 

 “Master Lease Agreement: means the Master Lease Agreement
entered into on the Amendment No. 2 Effective Date by and among the Company, Muskogee Regional Medical Center, LLC, Muskogee Community Hospital LLC, MCH Management, LLC and certain other parties thereto, pursuant to which Muskogee Regional
Medical Center, LLC leases the hospital facility (and all related equipment and improvements) known as Muskogee Community Hospital.” 
 (b) Section 10.2.1 of the Loan Agreement is amended by deleting the “and” at the end of clause (t) thereof and the period at the end of clause (u) thereof, inserting “;
and” at the end of clause (u) thereof and inserting the following new clause (v): 
 “(v) Debt
under the Master Lease Agreement and under the Promissory Note (as defined in the Master Lease Agreement).” 
 (c) Section 10.2.2 of the Loan Agreement is amended by deleting the “and” at the end of clause (t) thereof and the period at the end of clause (u) thereof, inserting “;
and” 
 at the end of clause (u) thereof and inserting the following new clause (v): 

“(v) Liens created by the Master Lease Agreement as in effect on the Amendment No. 2 Effective Date;”

 SECTION 1.03 Effectiveness. This Agreement and the consent contained herein shall not be binding
upon Agent or any Lender until each of the following conditions precedent has been satisfied in form and substance satisfactory to Agent and Lenders: 
 (a) The representations and warranties contained herein and in the Loan Agreement shall be true and correct in all material respects as of the date hereof as if made on the date hereof, except for those
representations and warranties that are limited by their terms to a specific date (such representations and warranties being true and correct in all material respects as of the specified date relative thereto); 

(b) No Default or Event of Default shall have occurred and be continuing; 

(c) The Credit parties shall have delivered to Agent an executed counterpart of this Agreement; and 

(d) Borrowers shall have paid to Agent all fees, costs, and expenses owed to and/or incurred by Agent arising in connection with this
Agreement (including reasonable attorneys’ fees and expenses). 
 SECTION 1.04 Conditions. The consent
contained in clause (ii) of Section 1.01 is further conditioned upon the following: 
 (a) On the Closing Date
(as defined in the APA) of the Asset Purchase (i) the representations and warranties contained in the Loan Agreement shall be true and correct in all material respects as of the date thereof as if made on the date thereof, except for those

 
representations and warranties that are limited by their terms to a specific date (such representations and warranties being true and correct in all material respects as of the specified date
relative thereto) and (ii) no Default or Event of Default shall have occurred and be continuing. 
 (b) The Asset Purchase
is consummated pursuant to the terms and conditions of the APA without giving effect to any waivers, amendments, supplements or other modifications thereto unless such waivers, amendments, supplements or other modifications are approved by the Agent
in writing. 
 (c) The Asset Purchase and the Transaction are consummated in accordance with all applicable laws, rules or
regulations and all requisite approvals and consents (regulatory, governmental or otherwise) have been obtained. 
 (d) The
receipt by Agent of a certified true copy of the fully executed APA (within 15 Business Days after the execution thereof), together with final, execution copies of the other documents, instruments and agreements executed in connection therewith or
executed or to be executed in connection with the Transaction, in each case, in form and substance reasonably satisfactory to Agent and such other documents, instruments, agreements and opinions as the Agent shall reasonably request. 

(e) Each of the “Conditions to Obligations of Purchaser” set forth in Article VII of the APA shall have been met or satisfied
to the satisfaction of the Agent in all material respects without any waivers (or deemed waivers), amendments, supplements or modifications thereof that are not acceptable to the Agent (for the avoidance of doubt, all documents, instruments,
agreements, consents, approvals, and releases required under such conditions shall be in form and substance satisfactory to Agent). 
 (f) Not less than 5 Business Days prior to the Closing Date of the Asset Purchase, the Company shall have delivered to the Agent, the certificate required by clause (f) of the definition of Permitted
Acquisitions, certifying and confirming that the Asset Purchase constitutes a Permitted Acquisition. 
 (g) Prior to the closing
of the Asset Purchase, the Company shall furnish to the Agent such other material documentation and information relating to the Transaction, as reasonably requested by the Agent. 

(h) Receipt by the Agent of (i) such other documentation and information, other agreements, instruments, certificates and due
diligence materials as the Agent may reasonably request, which shall be in form and substance satisfactory to the Agent and (ii) a certificate of a Senior Officer of the Company (x) certifying to the Administrative Agent that all
conditions set forth in this Consent have been satisfied in all material respects and (y) attaching thereto (except to the extent waived by Agent) and attesting to the completeness of fully executed copies of the Transaction documents; all
licenses and permits to be obtained from governmental and regulatory authorities necessary to operate the Business; all third party consents, approvals and assignments necessary to operate the Business, all necessary lien releases and payoff
letters, each executed by MCH as required, each other party to such document, MRMC and/or the Company, together with all schedules and exhibits thereto, all closing deliverables made pursuant thereto, and all filings to be made in connection
therewith. 

 (i) MRMC and the Company having taken such other action and delivered such other documents
to create, perfect or protect the Agents’ Liens in the acquired assets as Agent may reasonably require, including new or amended Blocked Account Agreements and, if requested by Agent, Lien Waivers with respect to the real property subject to
the Lease from the lessor and mortgagees thereof. 
 ARTICLE II 

SECTION 2.01 Consent of the Subsidiary Guarantors. Each of the undersigned Subsidiary Guarantors hereby consents to
and acknowledges the consent contained herein and confirms and ratifies its guaranty of the Obligations of the Borrowers pursuant to its Guaranty and its obligations under each other Loan Document to which it is a party. 

SECTION 2.02 Representations and Warranties. Each Credit Party hereby represents and warrants to each Lender and the
Agent, on the date hereof, that after giving effect to this Agreement, the representations and warranties set forth in Section 9 of the Loan Agreement and in each other Loan Document, are true and correct in all material respects on and
as of the date hereof with the same effect as if made on and as of the date hereof, except to the extent such representations and warranties expressly relate solely to an earlier date. No Default or Event of Default has occurred and is continuing.

 SECTION 2.03 Instrument Pursuant to Loan Agreement. This Agreement is a Loan Document executed pursuant
to the Loan Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions of the Loan Agreement. 

SECTION 2.04 Counterparts. This Agreement may be executed in any number of counterparts and by the different parties
hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. 
 SECTION 2.05 Confirmation. Except as expressly amended by the terms hereof, all of the terms of the Loan Agreement and the other Loan Documents shall continue in full force and effect
and are hereby confirmed in all respects. 
 SECTION 2.06 Governing Law; Waiver of Jury Trial. This
Agreement shall be governed by the laws of the State of New York, and shall be further subject to the provisions of Sections 14.15 and 14.16 of the Loan Agreement. 

[signature pages follow] 

 IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Agreement to
be duly executed and delivered as of the date first above written. 
  

			
	BORROWERS:
	
	CAPELLA HEALTHCARE, INC., a Delaware corporation
		
	By:	 	/s/ Denise W. Warren
	Name:	 	Denise W. Warren
	Title:	 	Senior Vice President, CFO and Treasurer
	
	CAPELLA HOLDINGS OF OKLAHOMA, LLC
	 CAPITAL MEDICAL CENTER HOLDINGS, LLC

CAPITAL MEDICAL CENTER PARTNER, LLC

CMCH HOLDINGS, LLC

COLUMBIA MEDICAL GROUP—SOUTH PITTSBURG, INC.

COLUMBIA OLYMPIA MANAGEMENT, INC.

CULLMAN COUNTY MEDICAL CLINIC, INC.

CULLMAN HOSPITAL CORPORATION

CULLMAN SURGERY VENTURE CORP.

FARMINGTON CLINIC COMPANY, LLC

FARMINGTON HEART & VASCULAR CENTER, LLC

FARMINGTON HOSPITAL CORPORATION

FARMINGTON MISSOURI HOSPITAL COMPANY, LLC

GRANDVIEW PHYSICIAN GROUP, LLC

HARTSELLE PHYSICIANS, INC.

JACKSONVILLE MEDICAL PROFESSIONAL SERVICES, LLC

JACKSONVILLE SURGICAL AND

MEDICAL AFFILIATES, LLC

LAWTON HOLDINGS, LLC

LAWTON SURGERY INVESTMENTS COMPANY, LLC

MINERAL AREA PHARMACY AND DURABLE

MEDICAL EQUIPMENT, LLC

MUSKOGEE HOLDINGS, LLC

		
	By:	 	/s/ Denise W. Warren
	Name:	 	Denise W. Warren
	Title:	 	Vice President and Treasurer

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 MUSKOGEE MEDICAL AND SURGICAL ASSOCIATES, LLC

MUSKOGEE PHYSICIAN GROUP, LLC

MUSKOGEE REGIONAL MEDICAL CENTER, LLC

NATIONAL HEALTHCARE OF DECATUR, INC.

NATIONAL HEALTHCARE OF HARTSELLE, INC.

NATIONAL PARK CARDIOLOGY SERVICES, LLC

NATIONAL PARK FAMILY CARE, LLC

NATIONAL PARK PHYSICIAN SERVICES, LLC

NPMC HOLDINGS, LLC

NPMC, HOME HEALTH, LLC

NPMC, LLC
 OREGON HEALTHCORP, LLC
 PARKWAY MEDICAL CLINIC,
INC.
 QHG OF JACKSONVILLE, INC.

RUSSELLVILLE HOLDINGS, LLC

SEQUATCHIE VALLEY UROLOGY, LLC

SOUTHWESTERN EMERGENCY

DEPARTMENT PHYSICIAN SERVICES, LLC

SOUTHWESTERN MEDICAL CENTER, LLC

SOUTHWESTERN NEUROSURGERY PHYSICIANS, LLC

SOUTHWESTERN PHYSICIAN SERVICES, LLC

SOUTHWESTERN RADIOLOGY ASSOCIATES, LLC

SOUTHWESTERN SURGICAL AFFILIATES LLC

SP ACQUISITION CORP.

SPARTA HOSPITAL CORPORATION

ST. MARY’S HOLDINGS, LLC

ST. MARY’S PHYSICIAN SERVICES, LLC

ST. MARY’S REAL PROPERTY, LLC

WESTERN WASHINGTON HEALTHCARE, LLC

WILLAMETTE VALLEY CLINICS, LLC

WILLAMETTE VALLEY MEDICAL CENTER, LLC

WPC HOLDCO, LLC

		
	By:	 	/s/ Denise W. Warren
	Name:	 	Denise W. Warren
	Title:	 	Vice President and Treasurer

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	AGENT AND LENDERS:
	BANK OF AMERICA, N.A.,
	as Agent and Lender
		
	By:	 	/s/ Seth Benefield
	Name:	 	Seth Benefield
	Title:	 	Senior Vice President

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 BARCLAYS BANK PLC,
 as a Lender

		
	By:	 	/s/ Lisa Minigh
	Name:	 	Lisa Minigh
	Title:	 	Assistant Vice President

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK,
 as a Lender

		
	By:	 	/s/ Tom Randloph
	Name:	 	Tom Randloph
	Title:	 	Managing Director
		
	By:	 	/s/ David Christiansen
	Name:	 	David Christiansen
	Title:	 	Director

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 GENERAL ELECTRIC CAPITAL CORPORATION,
 as a Lender

		
	By:	 	/s/ Dennis Cloud
	Name:	 	Dennis Cloud
	Title:	 	Duly Authorized Signatory

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 DEUTSCHE BANK TRUST COMPANY AMERICAS,
 as a Lender

		
	By:	 	/s/ Carin Keegan
	Name:	 	Carin Keegan
	Title:	 	Director

  

			
	 DEUTSCHE BANK TRUST COMPANY AMERICAS,
 as a Lender

		
	By:	 	/s/ Marguerite Sutton
	Name:	 	Marguerite Sutton
	Title:	 	Director

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 MORGAN STANLEY BANK, N.A.,
 as a Lender

		
	By:	 	/s/ Alain Pelanne
	Name:	 	Alain Pelanne
	Title:	 	Authorized Signatory

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	 CITIBANK, N.A.,
 as a Lender

		
	By:	 	/s/ Shane Azzara
	Name:	 	Shane Azzara
	 Title:
	 	Director

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

 
			
	HEALTHCARE FINANCE GROUP, as a Lender
		
	By:	 	/s/ Dan Chapa
	Name:	 	Dan Chapa
	 Title:
	 	President

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

			
	GRANTORS:
	
	Each of the undersigned Grantors hereby acknowledges this Agreement and ratifies and confirms the Security Agreement is in full force and effect after giving effect to
this Agreement.
	
	 CANNON COUNTY HOSPITAL, LLC

CAPITAL MEDICAL CENTER PHYSICIANS, LLC

CAPITAL MEDICAL CENTER SPECIALTY PHYSICIANS, LLC

COLUMBIA CAPITAL MEDICAL CENTER LIMITED PARTNERSHIP

HOT SPRINGS NATIONAL PARK HOSPITAL HOLDINGS, LLC

NATIONAL PARK REAL PROPERTY, LLC

RIVER PARK HOSPITAL, LLC

RIVER PARK HOSPITALISTS, LLC

RIVER PARK PHYSICIAN GROUP, LLC

SAINT THOMAS/CAPELLA, LLC

WHITE COUNTY COMMUNITY HOSPITAL, LLC

		
	By:	 	/s/ Denise W. Warren
	Name:	 	Denise W. Warren
	Title:	 	Vice President and Treasurer

 CONSENT AGREEMENT AND AMENDMENT NO.2 TO LOAN AGREEMENT 

Signature Page 

  
 16EX-10.5

 Exhibit 10.5 
 Teradata 2012 Stock Incentive Plan 
 Director Restricted Share Unit Grant
Statement 
  

							
	 Name of Grantee
	 	 Soc. Sec. #
	 	 Date of Grant
	  	 No. of Restricted 
Share
Units

 You have been awarded a number of restricted share units (the “Share Units”) under the Teradata 2012
Stock Incentive Plan (the “Plan”), subject to the terms and conditions of this Director Restricted Share Unit Grant Statement (this “Statement”), the Plan and the Teradata Corporation Director Compensation Program (the
“Program”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Plan. 
 1. The Share Units will vest during the one-year period beginning on the date upon which the Share Units were granted (the “Date of Grant”), in equal quarterly installments (subject to
mathematical rounding performed by the third party Plan administrator) commencing three (3) months after the Date of Grant, provided you continue to serve as a Director of Teradata Corporation (“Teradata”) until each vesting date.
Notwithstanding the foregoing, if the Date of Grant of your Share Units is the date of an Annual Meeting of Stockholders, then, the fourth quarterly vesting will occur only if you continue to serve as a Director until the earlier of (a) the
first Annual Meeting of Stockholders following the Date of Grant and (b) the first (1st) anniversary of the Date of Grant. 
 2. The Share Units will become fully vested if, prior
to the one-year anniversary of the Date of Grant, you die while serving as a Director of Teradata. 
 3. The vesting schedule will accelerate
and the Share Units will become fully vested if, prior to the one-year anniversary of the Date of Grant, a Change in Control occurs. 
 4.
Except as otherwise provided pursuant to a deferral election in effect under Article IV of the Program, when vested, the Share Units will be paid to you in shares of Teradata common stock, such that one (1) Share Unit equals one (1) share
of Teradata common stock (“Share”). 
 5. The Share Units will be cancelled if the Committee on Directors and Governance of the
Teradata Board of Directors determines that you engaged in misconduct in connection with your appointment as a Director of Teradata or if your service as a Director is terminated for Cause. Further, if your service as a Director is terminated for
Cause, then, to the extent demanded by the Committee on Directors and Governance of the Teradata Board of Directors in its sole discretion, you shall (a) return to Teradata all Shares that you have not disposed of that have been acquired
pursuant to this Statement, and (b) with respect to any Shares acquired pursuant to this Statement that you have disposed of, pay to Teradata in cash the Fair Market Value of such Shares on the date acquired. 

6. Any cash dividends declared before your vesting dates on the Shares underlying the Share Units shall be converted to additional Share Units subject to
the terms of this Statement, 

 
based on the Fair Market Value (as defined in the Plan) of Teradata common stock on the date the dividend is declared. 
 7. You may designate one or more beneficiaries to receive all or part of any Shares to be distributed in case of your death, and you may change or revoke such designation at any time. In the event of your
death, any Shares distributable hereunder that are subject to such a designation will be distributed to such beneficiary or beneficiaries in accordance with this Statement. Any other Shares will be distributable to your estate. If there shall be any
question as to the legal right of any beneficiary to receive a distribution hereunder, the Shares in question may be transferred to your estate, in which event Teradata will have no further liability to anyone with respect to such Shares.

 8. The terms of this award of Share Units as evidenced by this agreement may be amended by the Teradata Board of Directors or its Committee
on Directors and Governance or Compensation and Human Resource Committee, provided that no such amendment shall impair your rights hereunder without your consent. 
 9. The Share Units and the number and kind of Shares covered by this Statement shall be subject to adjustment as provided in Section 14 of the Plan. 

10. In the event of a conflict between the terms and conditions of this Statement and the terms and conditions of the Plan, the terms and conditions of
the Plan shall prevail. 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]